432 filings
Page 2 of 22
S-8 POS
soq42aekewm5y lu
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:34am
S-8 POS
3fm0ntcyqbn4h4l5l vi
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:33am
S-8 POS
gyejrg6fktzlhznf
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:32am
S-8 POS
4qrztbmx68 qe876s5yi
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:29am
S-8 POS
1r6jr
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:27am
S-8 POS
ken12a
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:20am
8-K
12ek vrktmi
22 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
efg 3otgk
15 Mar 23
Entry into a Material Definitive Agreement
6:05am
8-K
at20f1p20bui8k 6ax
13 Mar 23
Other Events
8:00am
8-K
rligmv
3 Feb 23
Cost Associated with Exit or Disposal Activities
6:02am
8-K
3axm jrqv0tfp694b5
5 Jan 23
Entry into a Material Definitive Agreement
9:26am
8-K
0qnj1aau3iv6
4 Jan 23
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
4:13pm
8-K
jy8tvu3 6x44r7y
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
wi628ud
5 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
1hmxrvpcidcxrz3ll
16 Nov 22
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
5:26pm
8-K
fs4y5voyp
16 Nov 22
Other Events
4:59pm
8-K
y3qx6 p66
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
8-K
ex2h2jk
2 Nov 22
Material Modifications to Rights of Security Holders
8:00am